Risk factors for progression of subclinical diabetic macular oedema

Kavita Bhavsar, Manju L. Subramanian

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Backgroud/aims: The purpose of this study was to determine the incidence of, and risk factors dictating, progression of subclinical macular oedema (SCME) to clinically significant macular oedema (CSME) in patients with diabetes. Methods: This was a retrospective, observational case-controlled study at the Veterans Administration (VA) Boston Healthcare System. The study group included subjects with central subfield macular thickness (CSMT) of 200-300 μm, measured by optical coherence tomography, compared with a control group with foveal thickness of

Original languageEnglish (US)
Pages (from-to)671-674
Number of pages4
JournalBritish Journal of Ophthalmology
Volume95
Issue number5
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Macular Edema
United States Department of Veterans Affairs
Optical Coherence Tomography
Delivery of Health Care
Control Groups
Incidence

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Risk factors for progression of subclinical diabetic macular oedema. / Bhavsar, Kavita; Subramanian, Manju L.

In: British Journal of Ophthalmology, Vol. 95, No. 5, 05.2011, p. 671-674.

Research output: Contribution to journalArticle

@article{0b4ed8273e324e7692a230ea38bbe0db,
title = "Risk factors for progression of subclinical diabetic macular oedema",
abstract = "Backgroud/aims: The purpose of this study was to determine the incidence of, and risk factors dictating, progression of subclinical macular oedema (SCME) to clinically significant macular oedema (CSME) in patients with diabetes. Methods: This was a retrospective, observational case-controlled study at the Veterans Administration (VA) Boston Healthcare System. The study group included subjects with central subfield macular thickness (CSMT) of 200-300 μm, measured by optical coherence tomography, compared with a control group with foveal thickness of",
author = "Kavita Bhavsar and Subramanian, {Manju L.}",
year = "2011",
month = "5",
doi = "10.1136/bjo.2010.182337",
language = "English (US)",
volume = "95",
pages = "671--674",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "5",

}

TY - JOUR

T1 - Risk factors for progression of subclinical diabetic macular oedema

AU - Bhavsar, Kavita

AU - Subramanian, Manju L.

PY - 2011/5

Y1 - 2011/5

N2 - Backgroud/aims: The purpose of this study was to determine the incidence of, and risk factors dictating, progression of subclinical macular oedema (SCME) to clinically significant macular oedema (CSME) in patients with diabetes. Methods: This was a retrospective, observational case-controlled study at the Veterans Administration (VA) Boston Healthcare System. The study group included subjects with central subfield macular thickness (CSMT) of 200-300 μm, measured by optical coherence tomography, compared with a control group with foveal thickness of

AB - Backgroud/aims: The purpose of this study was to determine the incidence of, and risk factors dictating, progression of subclinical macular oedema (SCME) to clinically significant macular oedema (CSME) in patients with diabetes. Methods: This was a retrospective, observational case-controlled study at the Veterans Administration (VA) Boston Healthcare System. The study group included subjects with central subfield macular thickness (CSMT) of 200-300 μm, measured by optical coherence tomography, compared with a control group with foveal thickness of

UR - http://www.scopus.com/inward/record.url?scp=79955031848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955031848&partnerID=8YFLogxK

U2 - 10.1136/bjo.2010.182337

DO - 10.1136/bjo.2010.182337

M3 - Article

C2 - 21071757

AN - SCOPUS:79955031848

VL - 95

SP - 671

EP - 674

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 5

ER -